Literature DB >> 29076873

Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases.

Alena Skalova1,2, Tomas Vanecek3, Petr Martinek3, Ilan Weinreb4, Todd M Stevens5, Roderick H W Simpson6, Martin Hyrcza7, Niels J Rupp8, Martina Baneckova1,2, Michael Michal1,9, David Slouka10, Tomas Svoboda11, Alena Metelkova12, Arghavan Etebarian13, Jaroslav Pavelka3,14, Steven J Potts15, Jason Christiansen15, Petr Steiner1,3, Michal Michal1.   

Abstract

ETV6 gene abnormalities are well described in tumor pathology. Many fusion partners of ETV6 have been reported in a variety of epithelial, mesenchymal, and hematological malignancies. In salivary gland tumor pathology, however, the ETV6-NTRK3 translocation is specific for (mammary analog) secretory carcinoma, and has not been documented in any other salivary tumor type. The present study comprised a clinical, histologic, and molecular analysis of 10 cases of secretory carcinoma, with typical morphology and immunoprofile harboring a novel ETV6-RET translocation.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29076873     DOI： 10.1097/PAS.0000000000000972

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN： 0147-5185            Impact factor:   6.394


  26 in total

1.  Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.

Authors:  Diana Bell; Renata Ferrarotto; Li Liang; Ryan P Goepfert; Jie Li; Jing Ning; Russell Broaddus; Randal S Weber; Adel K El-Naggar
Journal:  Virchows Arch       Date:  2019-08-19       Impact factor: 4.064

2.  Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing.

Authors:  Michael Seager; Dara L Aisner; Kurtis D Davies
Journal:  J Vis Exp       Date:  2019-07-05       Impact factor: 1.355

3.  Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.

Authors:  Bin Xu; Mohamed R Haroon Al Rasheed; Cristina R Antonescu; Deepu Alex; Denise Frosina; Ronald Ghossein; Achim A Jungbluth; Nora Katabi
Journal:  Histopathology       Date:  2019-12-11       Impact factor: 5.087

4.  Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.

Authors:  Min-Shu Hsieh; Yung-Ming Jeng; Yi-Hsuan Lee
Journal:  Virchows Arch       Date:  2019-06-11       Impact factor: 4.064

Review 5.  Salivary-Like Tumors of the Thyroid: A Comprehensive Review of Three Rare Carcinomas.

Authors:  Meagan Chambers; Vânia Nosé; Peter M Sadow; Laura J Tafe; Darcy A Kerr
Journal:  Head Neck Pathol       Date:  2020-06-19

6.  (Mammary Analogue) Secretory Carcinoma of the Nasal Cavity: Report of a Rare Case with p63 and DOG1 Expression and Uncommon Exon 4-Exon 14 ETV6-NTRK3 Fusion Diagnosed with Next Generation Sequencing.

Authors:  Bingcheng Wu; Thomas Kwok Seng Loh; Tomas Vanecek; Michal Michal; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2019-07-04

7.  Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.

Authors:  Bin Xu; Kartik Viswanathan; Kavita Umrau; Thair A D Al-Ameri; Snjezana Dogan; Kelly Magliocca; Ronald A Ghossein; Nicole A Cipriani; Nora Katabi
Journal:  Histopathology       Date:  2022-09-05       Impact factor: 7.778

8.  Clinicopathologic and Molecular Characterization of Four Cases of Pediatric Salivary Secretory Carcinoma (SSC), One with ETV6-RET Fusion.

Authors:  Cláudia M Salgado; Rita Alaggio; Miguel Reyes-Múgica; Angelica Zin; Rita de Vito
Journal:  Head Neck Pathol       Date:  2021-01-18

9.  A Poorly Differentiated Non-keratinizing Sinonasal Squamous Cell Carcinoma with a Novel ETV6-TNFRSF8 Fusion Gene.

Authors:  Justin Bubola; Christina M MacMillan; Ilan Weinreb; Ian Witterick; David Swanson; Lei Zhang; Cristina R Antonescu; Brendan C Dickson
Journal:  Head Neck Pathol       Date:  2021-01-04

10.  Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases.

Authors:  David Suster; Michael Michal; Michiya Nishino; Simonetta Piana; Massimo Bongiovanni; Olga Blatnik; Veronika Hájková; Nikola Ptáková; Michal Michal; Saul Suster
Journal:  Mod Pathol       Date:  2020-04-14       Impact factor: 7.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.